Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA: 600380)

Market Cap	21.12B
Revenue (ttm)	15.89B
Net Income (ttm)	1.47B
Shares Out	1.87B
EPS (ttm)	0.78
PE Ratio	14.37
Forward PE	13.83
Dividend	0.18 (1.60%)
Ex-Dividend Date	Jul 18, 2024

Volume	9,322,084
Open	11.20
Previous Close	11.18
Day's Range	11.19 - 11.41
52-Week Range	9.40 - 13.25
Beta	0.42
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 8, 2025

About Joincare Pharmaceutical Group Industry Co.,Ltd.

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 14,365
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600380

Financial Performance

In 2023, Joincare Pharmaceutical Group Industry Co.,Ltd.'s revenue was 16.65 billion, a decrease of -2.90% compared to the previous year's 17.14 billion. Earnings were 1.44 billion, a decrease of -3.99%.